标题
Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-23
DOI
10.1007/s12325-021-01876-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The presence of Hürthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates
- (2020) Yin Ren et al. THYROID
- Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
- (2020) Vera Wenter et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile
- (2020) Jasna Metovic et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
- (2020) Shoko Kure et al. Cancers
- Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas
- (2019) Wissem Amouri et al. NUCLEAR MEDICINE COMMUNICATIONS
- Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)
- (2019) Qiong Yang et al. PeerJ
- Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
- (2019) Mehtap Derya Aydemirli et al. Cancers
- Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
- (2018) Raj K. Gopal et al. CANCER CELL
- Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes
- (2018) Ian Ganly et al. CANCER CELL
- Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience
- (2016) Nikola Besic et al. BMC CANCER
- Radioactive Iodine Treatment Is Associated with Improved Survival for Patients with Hürthle Cell Carcinoma
- (2016) Christa L. Jillard et al. THYROID
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
- (2016) Bryan R. Haugen et al. THYROID
- Hürthle cell carcinoma: current perspectives
- (2016) Sara Ahmadi et al. OncoTargets and Therapy
- Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid
- (2015) Ana-Maria Chindris et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
- (2015) Martin Schlumberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- (2015) L. Shamseer et al. BMJ-British Medical Journal
- Clinicopathologic Features and Outcome of the Oncocytic Variant of Papillary Thyroid Carcinoma
- (2014) Menachem Gross et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Prognostic factors for disease-specific survival in 108 patients with Hürthle cell thyroid carcinoma: a single-institution experience
- (2014) Rok Petric et al. BMC CANCER
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data
- (2014) Won Gu Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Does Hürthle Cell Carcinoma of the Thyroid Have a Poorer Prognosis than Ordinary Follicular Thyroid Carcinoma?
- (2013) Kiminori Sugino et al. ANNALS OF SURGICAL ONCOLOGY
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
- (2013) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genomic Dissection of Hurthle Cell Carcinoma Reveals a Unique Class of Thyroid Malignancy
- (2013) Ian Ganly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hurthle cell carcinoma: An update on survival over the last 35 years
- (2013) Sapna Nagar et al. SURGERY
- Hurthle cell carcinoma
- (2012) Paolo Goffredo et al. CANCER
- Histological Patterns of Locoregional Recurrence in Hürthle Cell Carcinoma of the Thyroid Gland
- (2012) Justin A. Bishop et al. THYROID
- Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma
- (2012) Marlon A. Guerrero et al. Journal of Cancer
- The predicting factors for clinical outcomes in patients with Hürthle cell carcinoma: how we do it
- (2011) S. Kutun et al. CLINICAL OTOLARYNGOLOGY
- Neoadjuvant Chemotherapy in 29 Patients with Locally Advanced Follicular or Hürthle Cell Thyroid Carcinoma: A Phase 2 Study
- (2011) Nikola Besic et al. THYROID
- Oncocytic Neoplasms of the Thyroid Gland
- (2010) Giovanni Tallini et al. PATHOLOGY INTERNATIONAL
- Oncocytic Cell Tumors of the Thyroid: Factors Predicting Malignancy and Influencing Prognosis, Treatment Decisions, and Outcomes
- (2009) Adolfo Pisanu et al. WORLD JOURNAL OF SURGERY
- Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer
- (2008) Yevgeniya Kushchayeva et al. AMERICAN JOURNAL OF SURGERY
- Older Age and Larger Tumor Size Predict Malignancy in Hürthle Cell Neoplasms of the Thyroid
- (2008) Yi Wei Zhang et al. ANNALS OF SURGICAL ONCOLOGY
- HURTHLE CELL NEOPLASM OF THE THYROID GLAND
- (2008) Mohammed Ahmed et al. ANZ JOURNAL OF SURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started